Clinical Trial Update: CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing clarithromycin versus azithromycin for treatment of Mycobacterium avium complex lung infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Lung Disease

Drugs mentioned

• Azithromycin (azithromycin)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Lung Infection, MAC Lung Disease | Phase 3 | Status: RECRUITING